vs
Side-by-side financial comparison of 4D Molecular Therapeutics, Inc. (FDMT) and PagerDuty, Inc. (PD). Click either name above to swap in a different company.
PagerDuty, Inc. is the larger business by last-quarter revenue ($124.5M vs $85.1M, roughly 1.5× 4D Molecular Therapeutics, Inc.). PagerDuty, Inc. runs the higher net margin — 129.7% vs 22.8%, a 106.9% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 4.7%). 4D Molecular Therapeutics, Inc. produced more free cash flow last quarter ($28.5M vs $24.1M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 5.9%).
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
PagerDuty, Inc. is an American cloud computing company specializing in a SaaS incident management platform for IT operations departments.
FDMT vs PD — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $85.1M | $124.5M |
| Net Profit | $19.4M | $161.6M |
| Gross Margin | — | 85.3% |
| Operating Margin | 17.3% | 6.5% |
| Net Margin | 22.8% | 129.7% |
| Revenue YoY | 8508900.0% | 4.7% |
| Net Profit YoY | 139.1% | 2827.7% |
| EPS (diluted) | $0.43 | $1.69 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $85.1M | $124.5M | ||
| Q3 25 | $90.0K | $123.4M | ||
| Q2 25 | $15.0K | $119.8M | ||
| Q1 25 | $14.0K | $121.4M | ||
| Q4 24 | $1.0K | $118.9M | ||
| Q3 24 | $3.0K | $115.9M | ||
| Q2 24 | $5.0K | $111.2M | ||
| Q1 24 | $28.0K | $111.1M |
| Q4 25 | $19.4M | $161.6M | ||
| Q3 25 | $-56.9M | $9.6M | ||
| Q2 25 | $-54.7M | $-7.2M | ||
| Q1 25 | $-48.0M | $-8.8M | ||
| Q4 24 | — | $-5.9M | ||
| Q3 24 | $-43.8M | $-10.9M | ||
| Q2 24 | $-35.0M | $-17.1M | ||
| Q1 24 | $-32.4M | $-28.2M |
| Q4 25 | — | 85.3% | ||
| Q3 25 | — | 84.6% | ||
| Q2 25 | — | 84.0% | ||
| Q1 25 | — | 83.6% | ||
| Q4 24 | — | 83.0% | ||
| Q3 24 | — | 82.7% | ||
| Q2 24 | — | 82.6% | ||
| Q1 24 | — | 81.7% |
| Q4 25 | 17.3% | 6.5% | ||
| Q3 25 | -67983.3% | 2.9% | ||
| Q2 25 | -396373.3% | -8.6% | ||
| Q1 25 | -383007.1% | -9.6% | ||
| Q4 24 | — | -8.7% | ||
| Q3 24 | -1704400.0% | -13.8% | ||
| Q2 24 | -849120.0% | -19.5% | ||
| Q1 24 | -136200.0% | -30.1% |
| Q4 25 | 22.8% | 129.7% | ||
| Q3 25 | -63195.6% | 7.8% | ||
| Q2 25 | -364386.7% | -6.0% | ||
| Q1 25 | -342657.1% | -7.2% | ||
| Q4 24 | — | -5.0% | ||
| Q3 24 | -1461433.3% | -9.4% | ||
| Q2 24 | -699060.0% | -15.4% | ||
| Q1 24 | -115717.9% | -25.3% |
| Q4 25 | $0.43 | $1.69 | ||
| Q3 25 | $-1.01 | $0.10 | ||
| Q2 25 | $-0.98 | $-0.07 | ||
| Q1 25 | $-0.86 | $-0.12 | ||
| Q4 24 | — | $-0.07 | ||
| Q3 24 | $-0.79 | $-0.14 | ||
| Q2 24 | $-0.63 | $-0.26 | ||
| Q1 24 | $-0.66 | $-0.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $402.7M | $547.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $505.7M | $320.5M |
| Total Assets | $566.7M | $1.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $402.7M | $547.8M | ||
| Q3 25 | $305.1M | $567.9M | ||
| Q2 25 | $293.2M | $597.1M | ||
| Q1 25 | $321.4M | $570.8M | ||
| Q4 24 | $424.9M | $542.2M | ||
| Q3 24 | $501.9M | $599.3M | ||
| Q2 24 | $541.9M | $592.8M | ||
| Q1 24 | $525.9M | $571.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $484.5M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $489.5M |
| Q4 25 | $505.7M | $320.5M | ||
| Q3 25 | $369.0M | $180.7M | ||
| Q2 25 | $420.9M | $145.7M | ||
| Q1 25 | $469.7M | $129.8M | ||
| Q4 24 | $510.6M | $111.6M | ||
| Q3 24 | $552.9M | $164.7M | ||
| Q2 24 | $588.3M | $174.0M | ||
| Q1 24 | $600.6M | $171.6M |
| Q4 25 | $566.7M | $1.0B | ||
| Q3 25 | $424.0M | $891.5M | ||
| Q2 25 | $473.6M | $926.8M | ||
| Q1 25 | $515.7M | $927.3M | ||
| Q4 24 | $560.4M | $866.8M | ||
| Q3 24 | $604.0M | $916.0M | ||
| Q2 24 | $620.1M | $924.0M | ||
| Q1 24 | $629.9M | $925.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 3.73× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 2.85× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.6M | $24.8M |
| Free Cash FlowOCF − Capex | $28.5M | $24.1M |
| FCF MarginFCF / Revenue | 33.5% | 19.3% |
| Capex IntensityCapex / Revenue | 0.1% | 0.6% |
| Cash ConversionOCF / Net Profit | 1.47× | 0.15× |
| TTM Free Cash FlowTrailing 4 quarters | $-109.9M | $117.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.6M | $24.8M | ||
| Q3 25 | $-46.5M | $34.0M | ||
| Q2 25 | $-43.4M | $30.7M | ||
| Q1 25 | $-47.8M | $31.4M | ||
| Q4 24 | $-134.6M | $22.1M | ||
| Q3 24 | $-29.4M | $35.8M | ||
| Q2 24 | $-30.2M | $28.6M | ||
| Q1 24 | $-29.1M | $22.2M |
| Q4 25 | $28.5M | $24.1M | ||
| Q3 25 | $-46.6M | $33.1M | ||
| Q2 25 | $-43.4M | $30.2M | ||
| Q1 25 | $-48.4M | $30.3M | ||
| Q4 24 | $-138.4M | $21.5M | ||
| Q3 24 | $-31.2M | $35.1M | ||
| Q2 24 | $-30.6M | $28.2M | ||
| Q1 24 | $-29.8M | $21.2M |
| Q4 25 | 33.5% | 19.3% | ||
| Q3 25 | -51765.6% | 26.8% | ||
| Q2 25 | -289620.0% | 25.2% | ||
| Q1 25 | -345635.7% | 24.9% | ||
| Q4 24 | -13837100.0% | 18.1% | ||
| Q3 24 | -1038966.7% | 30.3% | ||
| Q2 24 | -611840.0% | 25.4% | ||
| Q1 24 | -106421.4% | 19.1% |
| Q4 25 | 0.1% | 0.6% | ||
| Q3 25 | 101.1% | 0.7% | ||
| Q2 25 | 440.0% | 0.4% | ||
| Q1 25 | 4507.1% | 0.9% | ||
| Q4 24 | 378600.0% | 0.5% | ||
| Q3 24 | 59266.7% | 0.5% | ||
| Q2 24 | 6980.0% | 0.4% | ||
| Q1 24 | 2535.7% | 0.9% |
| Q4 25 | 1.47× | 0.15× | ||
| Q3 25 | — | 3.55× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FDMT
Segment breakdown not available.
PD
| US | $88.8M | 71% |
| Non Us | $35.7M | 29% |
